Posted by | April 9, 2012 10:19 | Filed under: Top Stories

A vaccine that targets a molecule in 90% of all cancers is now being tested on humans.

Results from the safety trial – on patients with blood cancer – found all had greater immunity to the disease after receiving the vaccine. Three of the seven patients who have completed the treatment are now free of the condition.

As a therapeutic vaccine it is designed to be given to patients to help their bodies fight cancer rather than the majority – known as prophylactic vaccines – that aim to prevent disease in the first place.

Researchers believe the jab could also tackle breast, prostate, pancreatic, bowel and ovarian cancers.

Click here for reuse options!
Copyright 2012 Liberaland
By: Alan

Alan Colmes is the publisher of Liberaland.